All Type of News
Pharmaceutical SMEs struggle for survival
Experts are now raising concerns that the looming collapse of domestic pharmaceutical firms might in the long run lead to a de-industrialization of the country’s pharmaceutical industry, which faces cutthroat competit...
Ministry’s probe raises suspicions
The Ministry of Health and Welfare will bring criminal charges against ten drug makers who benefitted several hundreds of billion won from the manufacture of generics with better prices, despite the use of some cheap ...
Sanofi-Pasteur redistributes hepatitis A vaccine
Sanofi-Pasteur says it has redistribute Avaxim (inactivated hepatitis A) vaccine 80U in pediatrics of 1-15 years and adolescents, which has been in short supply from 2009.
The vaccine contained in a 0.5 mL pre-fill...
Government to slash drug prices by 14% on average
The Ministry of Health and Welfare said Monday that it plans to slash the price of about half the drugs on the market by an average of 14 percent. The plan is scheduled to take effect April 1.
The price cuts will b...
Pharmaceutical firms vow to defy government’s drug pricing reform
Asserting that the government’s “ill-conceived” plan, which was announced Monday, would shake the pharmaceutical industry to its roots, Korea Pharmaceutical Manufacturers Association (KPMA) pledged joint efforts to bl...
Multinational firms calls for review of massive drug price cut plan
The Korean Research based Pharmaceutical Industry Association (KRPIA) announced Tuesday that the government’s plan to cut drug prices by an average of 14 percent starting next year should be reviewed again among relat...
Restructuring to sweep pharmaceutical industry
Fierce competition in domestic drug market is making it harder for companies to do business.
Analysts expect a large number of drugs to be expelled from the market among companies, and restructuring seems inevitabl...
Prices of 7,500 insured-covered drugs to be lowed
In a move that is likely to curb current growth prospects for the local pharmaceutical industry, the government said Monday that it plans to cut drug prices by an average of 14% starting in 2012 as part of its efforts...
Corporate revenues up, profitability down
The third quarter report card for leading pharmaceutical companies is coming out, but despite of overall revenue hike, they saw their third-quarter operating profits worsen sharply, buffeted by higher costs and heavy ...
May KORUS FTA give benefis to pharmaceutical industry?
The ruling Grand National Party (GNP) is set to ratify the long-pending Korea-U.S. free trade agreement (KORUS FTA) soon as the ational Assembly is locked in an impasse with the ruling and the opposition parties showi...
